NKp80 Defines a Critical Step during Human Natural Killer Cell Development

Area of Science:

• Immunology
• Cell Biology
• Developmental Biology

Background:

• Human natural killer (NK) cells are crucial immune cells that develop in secondary lymphoid tissues (SLTs).
• NK cell development proceeds through distinct stages, but the precise markers and intermediates remain incompletely understood.

Purpose of the Study:

• To identify novel markers and stages in human NK cell development within SLTs.
• To characterize the functional and transcriptional differences between distinct NK cell subsets.

Main Methods:

• Flow cytometry was used to identify and sort NK cell subsets based on surface marker expression (Lin-, CD34-, CD117, CD94, CD16, NKp80).
• Quantitative PCR was employed to assess transcription factor expression (T-BET, EOMES, RORγt, AHR).
• Cytokine production (interferon-gamma, interleukin-22) and cytotoxicity assays were performed. Co-culture and in vivo transplantation models were utilized.

Main Results:

• Two distinct "stage 4" NK cell subsets were identified: NKp80- (stage 4a) and NKp80+ (stage 4b).
• Stage 4b cells exhibited characteristics of mature NK cells, including high T-BET/EOMES expression, interferon-gamma production, and cytotoxicity.
• Stage 4a cells shared features with stage 3 NK cells and innate lymphoid cells 3 (ILC3s), expressing RORγt/AHR and producing interleukin-22.
• Both stage 3 and stage 4a populations could differentiate into mature NK cells upon co-culture with dendritic cells or transplantation into immunodeficient mice.

Conclusions:

• NKp80 serves as a reliable marker for NK cell maturity in human secondary lymphoid tissues.
• Human NK cell development involves a stage 4a intermediate that possesses features associated with ILC3s.
• This study refines the model of human NK cell development, highlighting a potential link between NK cells and ILC3s during early development.